greenerRPP Greener, more sustainable platforms for high-value recombinant protein production
- Coordinator
- Academisch Ziekenhuis Groningen, Netherlands
- Runs
- 1 September 2022 to 31 August 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 16 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101073056
What the project is doing
In the project's own words, from its summary on CORDIS.
The greenerRPP project aims to markedly enhance the EU’s capacity for the production of secreted high-quality recombinant proteins, especially industrial enzymes and therapeutic proteins (biotherapeutics). The combined markets are in excess of $330 billion p.a., and the products are of massive significance for healthcare and a sustainable bio-based economy. greenerRPP will address urgent problems in these industries, such as difficult-to-express proteins and the rapidly-emerging issue of 'sustainability' in the European biotechnology industry.
It will deliver improvements in yield and process design that increase the industry's effectiveness while simultaneously reducing high current levels of waste. It will deliver industrial enzymes that reduce energy and raw material costs in countless industrial and domestic settings. To achieve this, we will develop powerful new microbial and mammalian cell platforms that produce recombinant proteins in unusually high quantities and in unparalleled quality, and bring to market a suite of super-producing platforms.
A comprehensive training programme will equip greenerRPP ESRs with the interdisciplinary and intersectoral skills required to be future leaders in these industries, while emphasising sustainability and gender-diversity dimension principles at every level. Finally, the programme addresses the stark global inequality in this biotechnology sector: recombinant protein production is largely carried out in (or outsourced by) high-income countries, placing low/middle income countries at a massive disadvantage. greenerRPP includes a series of South East Asian Institutions as Associated Partners, to develop a global network with a knowledge exchange-secondment programme that boosts these countries' own manufacturing programmes. greenerRPP ESRs will thus enhance a European industrial sector that has never been more important to society, while making it 'greener' and reaching out to lower income countries.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Coordinator |
| Boehringer Ingelheim Rcv GmbH & Co Kg | Wien | Austria | Participant |
| Eidgenoessische Technische Hochschule Zuerich | Zuerich | Switzerland | Associatedpartner |
| Fgen AG | Basel | Switzerland | Associatedpartner |
| AB Enzymes GmbH | Darmstadt | Germany | Associatedpartner |
| Universitaet Greifswald | Greifswald | Germany | Participant |
| Universitatsmedizin Greifswald Korperschaft Des Offentlichen Rechts | Greifswald | Germany | Participant |
| Oulun Yliopisto | Oulu | Finland | Participant |
| National Institute for Bioprocessing Research and Training Limited | Blackrock Dublin | Ireland | Participant |
| Universiti Malaysia Sabah | Kota Kinabalu | MY | Associatedpartner |
| Dsm Food Specialties BV | Delft | Netherlands | Participant |
| eV Biotech BV | Groningen | Netherlands | Associatedpartner |
| King Mongkut's University of Technology Thonburi | Bangkok | TH | Associatedpartner |
| Mahidol University | Nakhon Pathom | TH | Associatedpartner |
| University of Kent | Canterbury, Kent | United Kingdom | Associatedpartner |
| National Institute of Veterinary Research | Hanoi | VN | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI